Wired Herald

By 2026 Contraceptives Market Burst to Touch $38 Bn

Press release   •   Jul 31, 2019 07:03 EDT

According to Acumen Research and Consulting, The global Contraceptives Market Size is anticipated to around US$ 38 billion by 2026. The market is anticipated togrow at a CAGR of 7% from 2018 to 2026.

Acumen Research and Consulting has recently published a research report on the Contraceptives Market for the forecast period of 2018 to 2026, wherein, the global market has been analyzed and assessed in an extremely comprehensive manner. The research report on the Contraceptives Market offers an extensive analysis of how the postoperative pain therapeutics landscape would evolve through 2026.

The research study on the Contraceptives Market analyzes key drivers upholding product sales and prominent trends shaping the growth of the market. The research study not only focuses on the latent opportunities for the key stakeholders of the market, but also sheds light on the notable developments and future scope for innovation in the landscape.

The report starts off with a quick executive summary, wherein, key takeaways have been highlighted for the readers to have a sneak peak at the key market segments. The research study by ARC on the market also talks about the macroeconomic and microeconomic factors having deep-rooted influences on global market growth. The research study on the Contraceptives Market also offers a regional analysis, wherein, demand across every region has been comprehensively analyzed.

Download Free Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1253

The report also analyzes the Contraceptives Market on the basis of various segments, with drug type being a prominent one. A unique section in the report also offers a detailed breakdown on the basis of route of administration – which one is highly preferred and which one is minimally preferred.

Scope of the Contraceptives Market Report:

The study provides a decisive view of the Contraceptives Market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Market Segmentation:

Market by Product

  • Drugs
    • Oral contraceptive pills
    • Injectable contraceptives
    • Topical contraceptives
  • Devices
    • Condoms
      • Male condoms
      • Female condoms
  • Diaphragms
  • Contraceptive sponges
  • Vaginal rings
  • Subdermal implants
  • Intra-uterine devices
    • Copper IUD
    • Hormonal IUD

Market by Age

  • 15-19
  • 20-29
  • 30-39
  • 40-49

The market research study on “Contraceptives Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026” offers detailed insights on global Contraceptives Market segments with market dynamics and their impact. The report also covers basic technology development policies.

Key Questions Answered in the Report

The report addresses key questions concerning the market evolution and overarching trends shaping global market growth. Some of the key questions answered in the report include-

What is the overall structure of the market?

What was the historical value and what is the forecasted value of the market?

What are the key product level trends in the market?

What are the market level trends in the market?

Which of the market players are leading and what are their key differential strategies to retain their stronghold?

Which are the most lucrative regions in the market space?

Research Methodology

The report on the Contraceptives Market is based on an extensive and meticulous bottom up approach, which was used to determine the market size.

In the primary phase of the research methodology focus on, key stakeholders, including CEOs, presidents, vice presidents, chief medical officers, and product/sales/marketing managers were interviewed for the purpose of garnering unique insights into the dynamics of the market.

Market Participants:

Merck Co. Inc., Mithra Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Cipla Inc., Janssen Pharmaceutical Company, Pfizer Inc., Allergan plc, Mankind Pharma, Bayer AG, HLL Lifecare Limited, and Reckitt Benckiser plc.

VIEW FULL RESEARCH REPORT@ https://www.acumenresearchandconsulting.com/contraceptives-market

TABLE OF CONTENT

CHAPTER 1. Industry Overview

1.1. Definition and Scope
1.1.1. Definition of Contraceptives
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Contraceptives Market By Product
1.2.2.1. Global Contraceptives Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Contraceptives Market Revenue Share By Product in 2017
1.2.2.3. Drugs
1.2.2.3.1. Oral contraceptive pills
1.2.2.3.2. Injectable contraceptives
1.2.2.3.3. Topical contraceptives
1.2.2.4. Devices
1.2.2.4.1. Condoms
1.2.2.4.2. Diaphragms
1.2.2.4.3. Contraceptive sponges
1.2.2.4.4. Vaginal rings
1.2.2.4.5. Subdermal implants
1.2.2.4.6. Intra-uterine devices
1.2.2.5. Others
1.2.3. Contraceptives Market By Age
1.2.3.1. Global Contraceptives Market Revenue and Growth Rate Comparison By Age (2015-2026)
1.2.3.2. Global Contraceptives Market Revenue Share By Age in 2017
1.2.3.3. 15-19
1.2.3.4. 20-29
1.2.3.5. 30-39
1.2.3.6. 40-49
1.2.3.7. Others
1.2.4. Contraceptives Market by Geography
1.2.4.1. Global Contraceptives Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Contraceptives Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Contraceptives Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Contraceptives Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Contraceptives Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Contraceptives Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. Market Dynamics And Competition Analysis

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. Manufacturing Plants Analysis

3.1. Capacity and Commercial Production Date of Global Contraceptives Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Contraceptives Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Contraceptives Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Contraceptives Major Manufacturers in 2017

CHAPTER 4. Contraceptives Market By Product

4.1. Global Contraceptives Revenue By Product
4.2. Drugs
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.2.3. Oral contraceptive pills
4.2.4. Injectable contraceptives
4.2.5. Topical contraceptives
4.3. Devices
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3.3. Condoms
4.3.4. Diaphragms
4.3.5. Contraceptive sponges
4.3.6. Vaginal rings
4.3.7. Subdermal implants
4.3.8. Intra-uterine devices
4.4. Others
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. Contraceptives Market By Age

5.1. Global Contraceptives Revenue By Age
5.2. 15-19
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. 20-29
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. 30-39
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. 40-49
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.6. Others
5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.6.2. Market Revenue And Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. North America Contraceptives Market By Country

6.1. North America Contraceptives Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Contraceptives Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. U.S.
6.3.1. U.S. Contraceptives Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)

CHAPTER 7. Europe Contraceptives Market By Country

7.1. Europe Contraceptives Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Contraceptives Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)

CHAPTER 8. Asia-Pacific Contraceptives Market By Country

8.1. Asia-Pacific Contraceptives Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Contraceptives Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.8.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)

CHAPTER 9. Latin America Contraceptives Market By Country

9.1. Latin America Contraceptives Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Contraceptives Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)

CHAPTER 10. Middle East Contraceptives Market By Country

10.1. Middle East Contraceptives Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East Contraceptives Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)

CHAPTER 11. Africa Contraceptives Market By Country

11.1. Africa Contraceptives Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Africa Contraceptives Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Age, 2015 - 2026 ($Million)

CHAPTER 12. Company Profile

12.1. Merck Co. Inc.
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Mithra Pharmaceuticals
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Teva Pharmaceutical Industries Ltd.
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Cipla Inc.
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Janssen Pharmaceutical Company
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Pfizer Inc.
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Allergan plc
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. Mankind Pharma
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Bayer AG
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. HLL Lifecare Limited
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. Reckitt Benckiser plc.
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Product Portfolio
12.11.5. Key Developments
12.11.6. Strategies
12.12. Others
12.12.1. Company Snapshot
12.12.2. Overview
12.12.3. Financial Overview
12.12.4. Product Portfolio
12.12.5. Key Developments
12.12.6. Strategies

CHAPTER 13. RESEARCH APPROACH

13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

To Purchase this Premium Report@ https://www.acumenresearchandconsulting.com/buy-now/0/1253

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.